Carregant...

Duloxetine in the treatment of generalized anxiety disorder

Duloxetine is a serotonin-norepinephrine reuptake inhibitor (SNRI) which is FDA approved for the treatment of generalized anxiety disorder (GAD) in doses of 30 mg to 120 mg daily. Duloxetine has been shown to significantly improve symptoms of GAD as measured through the Hamilton Anxiety Rating Scale...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Wright, Alan, VanDenBerg, Chad
Format: Artigo
Idioma:Inglês
Publicat: Dove Medical Press 2009
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2840566/
https://ncbi.nlm.nih.gov/pubmed/20360899
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!